In contrast with previous reports, we also confirmed that the ITGB1/YBX1/SPP1/NF-κB signaling axis is correlated with drug resistance development in gastric cancer, and blockade of ITGB1/NF-κB signaling led to improved anticancer effects in a subcutaneous gastric cancer mouse model. This evidence concerns the gene YBX1 and gastric cancer.